Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mannkind Corp (NASDAQ:MNKD)

1.35
Delayed Data
As of 2:12pm ET
 -0.09 / -6.25%
Today’s Change
0.64
Today|||52-Week Range
7.32
-6.90%
Year-to-Date

Today’s Trading

Previous close1.44
Today’s open1.38
Day’s range1.33 - 1.41
Volume1,920,111
Average volume (3 months)7,039,340
Market cap$617.6M
Dividend yield--
Data as of 2:12pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+77.75%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SCLNSciClone Pharmaceuti...-0.04-0.30%
EPZMEpizyme Inc-0.69-6.24%
PDLIPDL BioPharma Inc-0.03-0.93%
EGRXEagle Pharmaceutical...-0.84-2.14%
Data as of 2:27pm ET, 04/29/2016

Financials

Next reporting dateMay 9, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts

Partner Offers

Search for Jobs